TrialBritish journal of cancer2018

Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.

B G Wortman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.